OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY CHANGES IN EARLY TYPE 3 NEOVASCULARIZATION AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT

被引:37
|
作者
Miere, Alexandra [1 ]
Querques, Giuseppe [2 ]
Semoun, Oudy [1 ]
Amoroso, Francesca [1 ]
Zambrowski, Olivia [1 ]
Chapron, Thibaut [1 ]
Capuano, Vittorio [1 ]
Souied, Eric H. [1 ]
机构
[1] Univ Paris Est, Ctr Hosp Intercommunal Creteil, Dept Ophthalmol, Creteil, France
[2] Univ Vita Salute San Raffaele, IRCCS, San Raffaele Sci Inst, Dept Ophthalmol, Milan, Italy
关键词
age-related macular degeneration; type; 3; neovascularization; chorioretinal anastomosis; retinal angiomatous proliferation; optical coherence tomography angiography; RETINAL ANGIOMATOUS PROLIFERATION; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; ANASTOMOSIS;
D O I
10.1097/IAE.0000000000001447
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To investigate the morphologic changes on optical coherence tomography angiography (OCTA) of treatment-naive Type 3 neovascularization secondary to exudative age-related macular degeneration after 1 year of anti-vascular endothelial growth factor therapy. Methods: Consecutive patients diagnosed with treatment-naive early-stage Type 3 neovascularization were enrolled in this retrospective study. All patients underwent color fundus photographs/MultiColor (Heidelberg Engineering) imaging, fluorescein angiography, indocyanine green angiography, structural spectral domain OCT, and OCTA Optovue RTVue XR Avanti (Optovue) at baseline, and repeated OCTA and structural spectral domain OCT at Month 12. Qualitative analysis of the 3 x 3 OCTA examinations at baseline and Month 12 was then compared, to assess changes after anti-vascular endothelial growth factor therapy. Results: A total of 15 treatment-naive eyes of 15 consecutive patients were included in the analysis. At 12-month follow-up after pro-re-data anti-vascular endothelial growth factor therapy (5.75 +/- 1.48 injections of ranibizumab, and injections of 6.33 +/- 1.21 of aflibercept), OCTA demonstrated persistence of the deep capillary plexus abnormalities in 13/15 eyes. In the outer retina and choriocapillaris, the initial lesion became undetectable in 7/15 cases, accompanied by choriocapillaris atrophy. The abnormal vascular complex persisted in the form of a tuft-shaped lesion in the outer retinal segmentation in 9/15 eyes, which in the choriocapillaris segmentation was associated with sub-retinal pigment epithelium neovascularization in 8 cases. Conclusion: Optical coherence tomography angiography showed that the tuft-shaped abnormal outer retinal lesion, frequently associated with a small clew-like flow signal in the choriocapillaris, after 1 year of anti-vascular endothelial growth factor therapy, either becomes undetectable or develops sub-retinal pigment epithelium neovascularization.
引用
收藏
页码:1873 / 1879
页数:7
相关论文
共 50 条
  • [31] Optical coherence tomography angiography analysis of changes in the foveal avascular zone in eyes with diabetic macular edema treated with intravitreal anti-vascular endothelial growth factor
    Albert John Bromeo
    Patricia Grulla-Quilendrino
    Ruth Camille Antolin
    Emil Joshua John Salcedo
    Cheryl A. Arcinue
    Ralph Anthony De Jesus
    Amadeo Veloso
    International Journal of Retina and Vitreous, 8
  • [32] Vascular Endothelial Growth Factor Gene and the Response to Anti-Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in High Myopia
    Miyake, Masahiro
    Yamashiro, Kenji
    Akagi-Kurashige, Yumiko
    Kumagai, Kyoko
    Nakata, Isao
    Nakanishi, Hideo
    Oishi, Akio
    Tsujikawa, Akitaka
    Yamada, Ryo
    Matsuda, Fumihiko
    Yoshimura, Nagahisa
    OPHTHALMOLOGY, 2014, 121 (01) : 225 - 233
  • [33] Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
    Wontae Yoon
    Jihyun Yoon
    Seung Kwan Na
    Jihyun Lee
    Jaemin Kim
    Jong Woo Kim
    Han Joo Cho
    Scientific Reports, 11
  • [34] Impact of macular fluid features on outcomes of anti-vascular endothelial growth factor treatment for type 3 macular neovascularization
    Yoon, Wontae
    Yoon, Jihyun
    Na, Seung Kwan
    Lee, Jihyun
    Kim, Jaemin
    Kim, Jong Woo
    Cho, Han Joo
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [35] Optical Coherence Tomography Angiography (OCTA) in Retinal Vein Occlusion following Anti-Vascular Endothelial Growth Factor (VEGF) Therapy for Retinal Edema
    Tripathy, Swetapadma
    Le, Hong-Gam T.
    Fawzi, Amani
    Liu, Jeffrey
    Gill, Manjot
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [36] Anti-vascular endothelial growth factor: the future treatment of choroidal neovascularization in pathologic myopia?
    Zhu Hong
    Wang Feng-hua
    Sun Xiao-dong
    CHINESE MEDICAL JOURNAL, 2013, 126 (08) : 1578 - 1583
  • [37] Evaluating the long-term effects of anti-vascular endothelial growth factor therapy on choroidal neovascularization in age-related macular degeneration using optical coherence tomography angiography
    Levine, Emily
    Greig, Eugenia Paula Custo
    Mendonca, Luisa
    Gulati, Shilpa
    Despotovic, Ivana
    Moult, Eric
    Fujimoto, James
    El-Maftouhi, Adil
    Quaranta-el Maftouhi, Maddalena
    Muakkassa, Nora
    Baumal, Caroline
    Witkin, Andre
    Duker, Jay
    Waheed, Nadia
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (09)
  • [38] Plasma levels of vascular endothelial growth factor and anti-vascular endothelial growth factor before and after intravitreal injection of anti-vascular endothelial growth factor
    Park, Sang Jun
    Yoon, Myung Hun
    Chung, Ah Reum
    Chin, Hee Seung
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [39] Response of Pediatric Choroidal Neovascularization to Anti-Vascular Endothelial Growth Factor
    Ruparelia, Sunil
    Sundaram, Aishwarya
    Dahrab, Mishari
    Symonds, Chris
    Cruess, Alan
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [40] Optical Coherence Tomography Angiography of Inflammatory Choroidal Neovascularization Early Response after Anti-VEGF Treatment
    Tang, Wenyi
    Guo, Jingli
    Liu, Wei
    Xu, Gezhi
    CURRENT EYE RESEARCH, 2020, 45 (12) : 1556 - 1562